1. Home
  2. IMAB vs OPAL Comparison

IMAB vs OPAL Comparison

Compare IMAB & OPAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMAB
  • OPAL
  • Stock Information
  • Founded
  • IMAB 2014
  • OPAL 1998
  • Country
  • IMAB United States
  • OPAL United States
  • Employees
  • IMAB N/A
  • OPAL N/A
  • Industry
  • IMAB Biotechnology: Pharmaceutical Preparations
  • OPAL Natural Gas Distribution
  • Sector
  • IMAB Health Care
  • OPAL Utilities
  • Exchange
  • IMAB Nasdaq
  • OPAL Nasdaq
  • Market Cap
  • IMAB 79.9M
  • OPAL 87.0M
  • IPO Year
  • IMAB 2020
  • OPAL N/A
  • Fundamental
  • Price
  • IMAB $0.97
  • OPAL $2.99
  • Analyst Decision
  • IMAB Strong Buy
  • OPAL Buy
  • Analyst Count
  • IMAB 3
  • OPAL 5
  • Target Price
  • IMAB $8.00
  • OPAL $6.78
  • AVG Volume (30 Days)
  • IMAB 280.2K
  • OPAL 106.9K
  • Earning Date
  • IMAB 03-13-2025
  • OPAL 03-12-2025
  • Dividend Yield
  • IMAB N/A
  • OPAL N/A
  • EPS Growth
  • IMAB N/A
  • OPAL N/A
  • EPS
  • IMAB N/A
  • OPAL 0.18
  • Revenue
  • IMAB $3,313,984.00
  • OPAL $306,957,000.00
  • Revenue This Year
  • IMAB N/A
  • OPAL $23.40
  • Revenue Next Year
  • IMAB N/A
  • OPAL $29.66
  • P/E Ratio
  • IMAB N/A
  • OPAL $16.87
  • Revenue Growth
  • IMAB N/A
  • OPAL 30.17
  • 52 Week Low
  • IMAB $0.84
  • OPAL $2.91
  • 52 Week High
  • IMAB $2.00
  • OPAL $5.18
  • Technical
  • Relative Strength Index (RSI)
  • IMAB 43.19
  • OPAL 35.05
  • Support Level
  • IMAB $1.03
  • OPAL $2.91
  • Resistance Level
  • IMAB $1.10
  • OPAL $3.12
  • Average True Range (ATR)
  • IMAB 0.06
  • OPAL 0.10
  • MACD
  • IMAB -0.01
  • OPAL -0.00
  • Stochastic Oscillator
  • IMAB 7.58
  • OPAL 17.84

About IMAB I-MAB

I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).

About OPAL OPAL Fuels Inc.

OPAL Fuels Inc is a fully integrated, nationwide leader in the production and distribution of low-carbon intensity renewable natural gas. The company is also engaged in the marketing and distribution of RNG to heavy-duty trucking and other hard-to-de-carbonize industrial sectors. The company designs, develops, constructs, operates, and services Fueling Stations for trucking fleets across the country that use natural gas to displace diesel as their transportation fuel. The company derives revenue from the sale of Renewable Power, design, development, construction, and service of Fueling Stations, and sales of RNG produced by OPAL and third parties as pipeline-quality natural gas.

Share on Social Networks: